Author: starbpo

The experimental Alzheimer’s drug donanemab from Eli Lilly & Co. got support from a group of outside advisors to the Food and Drug Administration on Monday, which was a step closer to getting approved in the U.S. The members of the FDA advisory committee all voted “yes” when asked if the experimental drug has been shown to help people with mild cognitive impairment and mild dementia who have Alzheimer’s disease. In a second vote, everyone on the committee agreed that donanemab is better for that group of patients than it is harmful. The FDA doesn’t have to do what the…

Read More

The 10-for-1 stock split that happened after Friday’s close has caused Nvidia Corp. stock to trade near $120 on Monday. For investors who are used to seeing Nvidia share prices NVDA, +0.75% close to $1,200, the lower stock price after the split may come as a shock. But it hasn’t been that long since Nvidia shares were worth about $120 before the split. This shows how quickly the company has grown over the past few years. Prices for Nvidia shares before the split were last seen at $120 in October 2022. That’s another way to show that Nvidia’s stock price…

Read More

UBS says that U.S. stocks seem to be back on track to hit new highs, even if there are delays due to unexpected inflation or the Federal Reserve’s upcoming two-day policy meeting. Jason Draho, head of asset allocation at the chief investment office of UBS Global Wealth Management, said that a low reading from May’s consumer-price index, which comes out on Wednesday, would “likely be sufficient for investors to remain confident in the disinflation outlook.” This would be similar to April’s 3.4% headline annual reading. “A big upside beat like those in 1Q would have to happen for investors to…

Read More

The “fear gauge” for the stock market is showing that things are looking good for the S&P 500. But below the surface, member stocks are becoming more and more independent. Because of this, six-month implied correlation for S&P 500 SPX members dropped to its lowest level ever last week, according to data from Cboe Global Markets. This is because individual stocks in the index are moving in lockstep much less often than they used to. The prices of stock options can show how investors think stocks will move in relation to each other over the next few months. This is…

Read More

Bill Gross said he wouldn’t feel comfortable investing a lot of money in U.S. stocks. He also said he liked European government bonds better than U.S. Treasurys, because the U.S. election could have a big effect on those bonds. In an interview that aired on Monday on Bloomberg Television, the billionaire co-founder of Pimco, who was once called the “Bond King,” talked about the stocks he liked, his worries about the overvaluation of stocks, and why he’s selling his $20 million stamp collection. “At 21 times current price to earnings, the stock market is valued at levels that have never…

Read More

Aeries Technology (Nasdaq: AERT) is a global professional services and consulting partner for businesses in transformation mode and their stakeholders, including portfolio companies of private equity sponsors and mid-segment enterprises. With customized engagement models that are designed to provide the right mix of deep vertical specialty and functional expertise, Aeries provides industry best practices and advanced digital systems and solutions to scale, optimize and transform a client’s business operations. Founded in 2012, Aeries Technology now has over 1,600 professionals across India and Mexico, specializing in Technology Services and Solutions, Business Process Management, and Digital Transformation. With its unique ‘Purpose-built’ business…

Read More

Monday, Microsoft stock was going up thanks to a bullish call from Pierre Ferragu, an analyst at NewStreet Research. The price of shares went up by 0.7%, to $426.68. Ferragu, who writes about many tech companies, officially started to cover Microsoft with a Buy rating and a $570 price target. That’s a 34% rise from Friday’s closing price of $423.85, which would make the world’s most valuable company worth more than $4 trillion. Microsoft has a market value of $3.17 billion. Apple is in second place with $2.99 trillion, and Nvidia is in third place with $2.92 trillion. According to…

Read More

A study by Moderna Inc. MRNA, -2.59% found that their experimental COVID and flu vaccine worked better than single shots on the market right now. The company released the results of the study on Monday. In the late stages of the trial, adults aged 65 and up were given the investigational combo shot mRNA-1083 along with the Sanofi SNY, -0.94% flu vaccine Fluzone HD and Moderna’s Spikevax COVID vaccine. The trial looked at the combination vaccine against GSK PLC’s GSK, -0.18% Fluarix flu vaccine and Spikevax in people aged 50 to 64. Moderna said that the two-in-one shot made people’s…

Read More

Shares of Southwest Airlines Co. had their best day in more than two years on Monday, when activist investor Elliott Investment Management L.P. said it had a big stake in the airline that wasn’t doing well. Elliott wrote to Southwest’s board of directors with ideas that he thought could increase the stock’s value by 77% in a year. These ideas included “upgrading” the company’s leadership and reviewing the whole business plan. When asked for a comment, Southwest did not respond right away. In morning trading, the stock LUV, 9.10% went up 6.4%. It has gone up 15.7% since May 29,…

Read More

Trueist raised the price of Krispy Kreme Inc. stock to buy and said it’s time to “indulge in an underappreciated story.” The stock went up 5.6% on Monday. After giving the stock DNUT a buy rating instead of a hold rating, analysts raised their price target for the next 12 months from $13 to $15. The team, led by Bill Chappell, recently went on a trip with Krispy Kreme’s CEO and finance head to meet with institutional clients. After those meetings, they were sure that most investors either don’t know about the story or get it wrong. It was based…

Read More